RNA-mediated toxicity in C9orf72 ALS and FTD

RNA-mediated toxicity in C9orf72 ALS and FTD

A GGGGCC hexanucleotide repeat expansion in the first intron of C9orf72 is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. Compelling evidence suggests that gain of toxicity from the bidirectionally transcribed repeat expanded RNAs plays a central role in...

Full description

Bibliographic Details
Main Authors:	Zachary T. McEachin, Janani Parameswaran, Nisha Raj, Gary J. Bassell, Jie Jiang
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	Neurobiology of Disease
Subjects:	Amyotrophic lateral sclerosis Frontotemporal dementia C9orf72 RNA-mediated toxicity RNA foci Dipeptide repeat proteins
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996120303302

Similar Items

C9ORF72 and the FTD-ALS spectrum: a systematic review of neuroimaging studies
by: Laura de Godoy Rousseff Prado, et al.

RNA Misprocessing in C9orf72-Linked Neurodegeneration
by: Holly V. Barker, et al.
Published: (2017-07-01)

Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
by: Xiaoqiang Tang, et al.
Published: (2020-06-01)

Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients
by: Daniel A. Mordes, et al.
Published: (2018-07-01)

HDAC6 Interacts With Poly (GA) and Modulates its Accumulation in c9FTD/ALS
by: Giulia del Rosso, et al.
Published: (2022-01-01)

Translation of dipeptide repeat proteins in C9ORF72 ALS/FTD through unique and redundant AUG initiation codons
by: Yoshifumi Sonobe, et al.
Published: (2023-09-01)

G‐quadruplex‐binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo
by: Roberto Simone, et al.
Published: (2017-11-01)

Role of C9orf72 hexanucleotide repeat expansions in ALS/FTD pathogenesis
by: Yanyan Geng, et al.
Published: (2024-01-01)

Breakdown of the central synapses in C9orf72-linked ALS/FTD
by: Layla T. Ghaffari, et al.
Published: (2022-09-01)

Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
by: Ileana Lorenzini, et al.
Published: (2023-06-01)

Synaptic dysfunction induced by glycine‐alanine dipeptides in C9orf72‐ALS/FTD is rescued by SV2 replenishment
by: Brigid K Jensen, et al.
Published: (2020-04-01)

Poly‐GP in cerebrospinal fluid links C9orf72‐associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD
by: Carina Lehmer, et al.
Published: (2017-04-01)

Neuronal Transcriptome from C9orf72 Repeat Expanded Human Tissue is Associated with Loss of C9orf72 Function
by: Elaine Y. Liu, et al.
Published: (2020-08-01)

Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration
by: Sarah Mizielinska, et al.
Published: (2017-04-01)

CRISPR interference to evaluate modifiers of C9ORF72-mediated toxicity in FTD
by: Sarah Pickles, et al.
Published: (2023-08-01)

Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD
by: Alexander Schmitz, et al.
Published: (2021-02-01)

Modeling C9orf72-Related Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Drosophila
by: Joanne L. Sharpe, et al.
Published: (2021-10-01)

C9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice
by: Maria-Belen Lopez-Herdoiza, et al.
Published: (2023-04-01)

C9orf72 gene networks in the human brain correlate with cortical thickness in C9-FTD and implicate vulnerable cell types
by: Iris J. Broce, et al.
Published: (2024-02-01)

Targeted long-read sequencing to quantify methylation of the C9orf72 repeat expansion
by: Evan Udine, et al.
Published: (2024-12-01)

Active poly‐GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model
by: Qihui Zhou, et al.
Published: (2019-12-01)

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
by: Rita Sattler, et al.
Published: (2023-10-01)

A comparative bioinformatic analysis of C9orf72
by: Shalini Iyer, et al.
Published: (2018-02-01)

Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity
by: Craig L. Bennett, et al.
Published: (2023-10-01)

Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation
by: Emiliano Giardina, et al.
Published: (2024-01-01)

Preclinical evaluation of WVE-004, aninvestigational stereopure oligonucleotide forthe treatment of C9orf72-associated ALS or FTD
by: Yuanjing Liu, et al.
Published: (2022-06-01)

Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients – An Atlas-Based Volumetric MRI Study
by: Sonja Schönecker, et al.
Published: (2018-03-01)

<i>C9orf72</i> Hexanucleotide Repeat Expansion-Related Neuropathology Is Attenuated by Nasal Rifampicin in Mice
by: Yukari Hatanaka, et al.
Published: (2022-05-01)

Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers
by: Petra Frick, et al.
Published: (2018-08-01)

Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity
by: Annelies Quaegebeur, et al.
Published: (2020-11-01)

Dipeptide Repeat Pathology in <i>C9orf72</i>-ALS Is Associated with Redox, Mitochondrial and NRF2 Pathway Imbalance
by: José Jiménez-Villegas, et al.
Published: (2022-09-01)

Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism
by: Erin G Conlon, et al.
Published: (2018-07-01)

The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion
by: Emma M Devenney, et al.
Published: (2017-01-01)

Reduced C9orf72 expression exacerbates polyGR toxicity in patient iPSC-derived motor neurons and a Type I protein arginine methyltransferase inhibitor reduces that toxicity
by: Therese L. Dane, et al.
Published: (2023-04-01)

C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import
by: Lindsey R Hayes, et al.
Published: (2020-03-01)

Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers
by: Dennis W. Dickson, et al.
Published: (2019-10-01)

Telomere Attrition in Induced Pluripotent Stem Cell-Derived Neurons From ALS/FTD-Related C9ORF72 Repeat Expansion Carriers
by: Hayley Robinson, et al.
Published: (2022-06-01)

Mouse Models of C9orf72 Hexanucleotide Repeat Expansion in Amyotrophic Lateral Sclerosis/ Frontotemporal Dementia
by: Ranjan Batra, et al.
Published: (2017-07-01)

A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in an AAV-C9ORF72 (G4C2)66 mouse model
by: Emily G. Thompson, et al.
Published: (2024-12-01)

Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy
by: Jeannie Chew, et al.
Published: (2019-02-01)